Every strategy for accessing GLP-1 medications at a price that’s actually sustainable — from compounded options to patient assistance programs
The brand name price of weight loss injections — $1,000-1,500 per month — puts them out of reach for most people without insurance coverage. But brand name retail pricing is not the only option. In fact, most people who access these medications pay significantly less — often 80-90% less — through pathways that most people don’t know exist.
Here’s the complete guide to every option for affording weight loss injections without insurance.
Why Brand Name Prices Aren’t the Whole Story
The $1,300/month Wegovy price that makes headlines is the retail price — what you’d pay walking into a pharmacy with no insurance, no discount program, and no alternative. Almost nobody actually pays this.
The landscape of actual prices people pay:
- Compounded semaglutide via telehealth: $150-350/month
- Compounded tirzepatide via telehealth: $200-500/month
- Manufacturer savings card (commercially insured): $0-50/month
- Patient assistance program (income-qualifying): $0/month
- GoodRx discount on brand name: $800-1,100/month (modest help)
- Diabetes indication with discount card: $200-400/month
The gap between the headline price and what people actually pay is enormous. Understanding each option helps find the right pathway for your specific situation.
Option 1: Compounded Medications Through Telehealth — Most Accessible
This is how the majority of people without insurance currently access GLP-1 medications — and represents the most dramatic price reduction available.
What Compounded Medications Are
FDA-registered compounding pharmacies can legally produce copies of medications when the brand name is on the FDA drug shortage list (as semaglutide and tirzepatide have been) or when a patient has specific medical needs requiring a customized formulation.
The active ingredient is the same — semaglutide or tirzepatide. The difference is that compounding pharmacies produce it independently rather than under the brand name manufacturer’s process.
The Price Reality
Compounded semaglutide:
- $150-350/month through reputable telehealth providers
- Annual cost: $1,800-4,200
- Compared to Wegovy brand: savings of $12,000-15,000 per year
Compounded tirzepatide:
- $200-500/month through reputable telehealth providers
- Annual cost: $2,400-6,000
- Compared to Zepbound brand: savings of $9,000-12,000 per year
How to Access Compounded Medications Safely
Use a reputable telehealth provider that:
- Employs actual licensed physicians or nurse practitioners (not algorithm-only approval)
- Sources from FDA-registered 503B compounding pharmacies
- Provides ongoing medical oversight and dose adjustment
- Has transparent pricing with no hidden fees
- Has verifiable contact information and medical staff
Gala offers compounded semaglutide and tirzepatide through licensed telehealth providers — with medical oversight throughout treatment.
[Check pricing and eligibility at Gala →]
This is a paid partnership. Gala is a licensed telehealth provider. Medication is only prescribed following a medical consultation and is not guaranteed.
The Regulatory Caveat
The FDA has been actively addressing compounded GLP-1 medications as drug shortages resolve. The availability and regulatory status of compounded versions changes — discuss current status with your telehealth provider and understand that this landscape may shift.
Red Flags to Avoid
Avoid telehealth providers that:
- Don’t require medical evaluation before prescribing
- Promise immediate approval regardless of medical history
- Have no identifiable medical staff
- Use 503A pharmacies rather than 503B (different regulatory standard)
- Offer prices dramatically below market ($50-80/month claims should raise concern)
- Don’t provide ongoing medical support
Option 2: Manufacturer Savings Programs — If You Have Any Insurance
Even if your insurance doesn’t cover weight loss medications specifically, manufacturer savings programs can dramatically reduce cost — but they require commercial insurance.
Novo Nordisk Savings Card (Wegovy/Ozempic):
- For commercially insured patients (not Medicare/Medicaid)
- Can reduce cost to $0-25/month for eligible patients
- Available at: novonordisk-us.com or through your pharmacy
- Time-limited — typically 12-24 months
Eli Lilly Savings Card (Zepbound/Mounjaro):
- Similarly for commercially insured patients
- Can reduce cost to $25-50/month for eligible patients
- Available at: zepbound.com/savings
The important limitation: These programs are explicitly not available to Medicare or Medicaid beneficiaries — federal law prohibits pharmaceutical companies from offering discounts to government program patients.
How to use them:
- Get prescription from your provider
- Download or print the savings card from manufacturer website
- Present at pharmacy alongside your prescription
- Pay the discounted copay
Option 3: Patient Assistance Programs — If Your Income Qualifies
For people who genuinely cannot afford medication costs, pharmaceutical manufacturers offer patient assistance programs providing medication at no cost.
Novo Nordisk Patient Assistance (NovoCare):
- For uninsured or underinsured patients meeting income requirements
- Typically requires income below 400% of federal poverty level
- Application through novonordisk-us.com/patients/patient-assistance
- Provides brand name Wegovy or Ozempic at no cost
Eli Lilly Patient Assistance:
- Similar income-based program for Zepbound/Mounjaro
- Application through lillycares.com
- Income verification required
What’s required:
- Proof of income (tax returns, pay stubs)
- Proof of US residency
- Prescription from licensed provider
- Completed application — typically processed in 2-4 weeks
The honest limitation: These programs have income caps and application processes that take time. They’re most accessible for people with clearly qualifying income situations — not a quick solution.
Option 4: The Diabetes Indication Pathway
If you have type 2 diabetes or prediabetes — the access equation changes significantly.
Why diabetes matters for cost:
Ozempic (semaglutide for diabetes) and Mounjaro (tirzepatide for diabetes) are FDA-approved for diabetes management — and most insurance plans covering diabetes medications include these.
Even without insurance, the diabetes indication opens additional discount pathways:
GoodRx for diabetes-indicated medications: GoodRx discounts are more meaningful for Ozempic/Mounjaro than for Wegovy/Zepbound:
- Ozempic with GoodRx: approximately $700-900/month (vs $900-1,000 retail)
- Mounjaro with GoodRx: approximately $700-850/month
Still expensive — but better than retail.
Manufacturer programs for diabetes indication: Both Novo Nordisk and Eli Lilly have separate savings programs for their diabetes-indicated medications that may have different eligibility criteria than the weight loss indication programs.
The important distinction: Ozempic tops out at 2mg — lower than Wegovy’s 2.4mg. For maximum weight loss, the higher Wegovy dose is preferable. But for people who qualify for diabetes indication and need to manage cost — Ozempic provides meaningful weight loss at lower cost.
Option 5: HSA and FSA Funds
Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) provide tax-advantaged dollars that can be used for prescription medications — including weight loss injections when prescribed for a qualifying medical condition.
The tax advantage:
Using pre-tax HSA/FSA dollars effectively reduces the cost by your marginal tax rate:
- If you’re in the 22% tax bracket: $300/month medication costs $234 in pre-tax dollars
- If you’re in the 24% tax bracket: $300/month costs $228 in pre-tax dollars
Over a year at $300/month, the HSA/FSA tax advantage saves approximately $792-864 compared to paying with after-tax dollars.
HSA specific advantages:
- Rolls over year to year — unused funds aren’t lost
- Grows tax-free if invested
- Can be used for any qualified medical expense
How to use:
- Pay for medication with HSA/FSA debit card directly
- Or pay out of pocket and submit for reimbursement
- Keep prescriptions and receipts as documentation
Contribution limits (2026):
- Individual HSA: $4,300/year
- Family HSA: $8,550/year
For someone using compounded medication at $250/month ($3,000/year) — HSA funds can cover the entire annual cost with room to spare.
Option 6: Employer Benefits — Often Overlooked
Many people don’t realize their employer may offer benefits that reduce medication costs:
Check with HR about:
Employee assistance programs (EAP): Some include health and wellness benefits that may contribute to medication costs.
Voluntary benefits: Some employers offer supplemental health insurance or disease management programs that cover weight loss treatment.
Benefits changes: Many employers have been adding GLP-1 medication coverage as clinical evidence has mounted — upcoming benefits enrollment periods may include new coverage.
Health reimbursement arrangements (HRA): Some employers offer HRAs that reimburse medical expenses — medication may qualify.
The simple action: Email your HR department asking specifically whether your benefits cover “GLP-1 medications for weight management including Wegovy or Zepbound” — you may be surprised.
Option 7: Clinical Trials
People who qualify for clinical trials of GLP-1 medications or next-generation weight loss medications receive the medication free — alongside close medical monitoring.
Finding trials:
- ClinicalTrials.gov — search “semaglutide obesity” or “tirzepatide weight loss”
- Filter by location and eligibility criteria
The honest tradeoffs:
- May be randomized to placebo (typically 50% chance in a trial)
- Requires frequent clinic visits
- May involve restrictions on other medications or activities
- Not appropriate for everyone
For people near academic medical centers — clinical trials represent a legitimate pathway to access cutting-edge weight loss medications at no cost.
Option 8: Medical Tourism (For Some)
In some countries, GLP-1 medications are available at significantly lower prices than in the US:
- Mexico: Ozempic and similar medications available for $200-400/month
- Canada: Lower regulated prices than US
- Turkey, India: Even lower prices
The considerations:
- Travel costs offset some savings unless near the border
- Medication must be for personal use — bringing back commercial quantities is illegal
- Authenticity concerns — counterfeit medications exist in some markets
- Prescription requirement varies by country
For people living near the Mexican border — cross-border pharmacy access is a legitimate cost reduction strategy used by many Americans for various medications.
Option 9: Splitting Higher-Dose Vials (Compounded Only)
Some compounding pharmacies provide semaglutide in multi-dose vials rather than pre-filled pens — at lower cost per dose. During dose escalation when you’re using lower doses, using a higher-concentration vial and drawing smaller amounts can reduce monthly cost.
This requires:
- Prescription for multi-dose vials specifically
- Comfort with drawing medication into a syringe
- Guidance from prescriber on accurate dosing
Not appropriate for everyone — but can reduce costs during the lower-dose escalation phase.
Building a Sustainable Cost Plan
Given that weight loss injections appear to require long-term use for most people — as covered in our guide to what happens when you stop weight loss injections — planning for ongoing cost is important.
The sustainable cost framework:
Short-term (months 1-6): Establish which medication works for you using compounded options through telehealth. Focus on finding a provider with consistent supply and quality.
Medium-term (months 6-18): As results become clear, evaluate whether:
- Continued compounded medication is the most cost-effective option
- Insurance situation has changed (new job, new benefits period)
- Patient assistance program eligibility exists
- Dose reduction (maintaining on lower dose) is possible
Long-term: Factor medication cost into ongoing budget — similar to how you’d budget for any chronic condition management. The HSA strategy, employer benefits research, and annual reassessment of available options are ongoing activities.
The dose reduction consideration:
Some people achieve significant weight loss at lower than maximum doses — and maintaining on a lower dose is cheaper. Discuss with your prescriber whether a maintenance dose lower than the maximum is appropriate for your situation.
The Cost vs. Value Calculation
When evaluating whether weight loss injections are affordable without insurance, the full cost picture includes what obesity costs:
Annual costs of obesity-related conditions:
- Type 2 diabetes management: $8,000-15,000/year
- Hypertension medications: $1,000-3,000/year
- Sleep apnea equipment: $500-2,000/year
- Joint pain management: $1,000-5,000/year
- Higher health insurance premiums: $1,000-3,000/year above non-obese rates
For people with multiple obesity-related conditions, the $2,000-4,000/year cost of compounded medication may be offset by reductions in other health spending — making the net cost lower than the medication price alone suggests.
Practical Next Steps
If you want to start as quickly and affordably as possible:
- Start with telehealth + compounded medication — fastest access, most affordable, clinically effective
- Check your employer benefits — simple email to HR may reveal coverage you didn’t know about
- Verify HSA/FSA eligibility — use pre-tax dollars to reduce effective cost
- Apply for patient assistance if income qualifies — free medication if eligible
- Check manufacturer savings cards if you have any commercial insurance
The realistic monthly cost for most people:
| Pathway | Monthly Cost |
|---|---|
| Compounded via telehealth | $150-400 |
| With HSA (22% bracket) | $117-312 |
| Patient assistance (if qualifying) | $0 |
| Manufacturer savings card (if insured) | $0-50 |
The Bottom Line
Brand name weight loss injection prices are real — but they’re not what most people pay.
The most accessible options without insurance:
- Compounded GLP-1 via telehealth ($150-400/month) — most people’s starting point
- Patient assistance programs ($0) — if income qualifies
- Manufacturer savings cards ($0-50/month) — if any commercial insurance exists
- HSA/FSA funds — reduce effective cost by tax rate
- Employer benefits check — may reveal unexpected coverage
The bottom line: $1,300/month brand name prices are not the barrier to access they appear. Most people can access effective GLP-1 medication for $150-400/month through compounded telehealth options — making long-term treatment financially feasible for a much broader population than brand name pricing suggests.
For the complete cost picture, see our guide to how much weight loss injections cost.
What pathway have you found to make weight loss injections affordable — and what advice would you give others navigating cost without insurance? Share in the comments.
